![Bethany Sensenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bethany Sensenig
Directeur/Bestuurslid bij
SUPERNUS PHARMACEUTICALS, INC.
Vermogen: 39 631 $ op 30-06-2026
Profiel
Bethany L.
Sensenig is currently Independent Director at Supernus Pharmaceuticals, Inc. since 2023, Independent Director at Alpha Cognition, Inc. starting in 2026, and Chief Executive & Financial Officer at Naia Rare Diseases LLC.
Former roles include Independent Director at KalVista Pharmaceuticals, Inc. from 2025 to 2026, Vice President-Finance & Commercial Operations at Biogen, Inc. from 2006 to 2019, Chief Financial Officer at Radius Health, Inc. from 2023 to 2026, Chief Executive & Financial Officer at 9 Meters Biopharma, Inc. in 2023, and Chief Financial Officer & Head-US Operations at Minovia Therapeutics Ltd. from 2019 to 2022.
Education includes undergraduate studies at Montreat College and an MBA from Western Carolina University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALPHA COGNITION INC 0,03% | 16-04-2026 | 5.489 ( 0,03% ) | 39 631 $ | 30-06-2026 |
| 29-04-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van Bethany Sensenig
| Bedrijven | Functie | Begin |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 21-08-2023 |
| ALPHA COGNITION INC. | Directeur/Bestuurslid | 15-04-2026 |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Algemeen Directeur | - |
Eerdere bekende functies van Bethany Sensenig
| Bedrijven | Functie | Einde |
|---|---|---|
| KALVISTA PHARMA | Directeur/Bestuurslid | 11-06-2026 |
| RADIUS HEALTH, INC. | Financieel Directeur/CFO | 01-04-2026 |
| 9 METERS BIOPHARMA, INC. | Algemeen Directeur | 17-07-2023 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Financieel Directeur/CFO | 01-01-2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01-03-2019 |
Opleiding van Bethany Sensenig
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Montreat College
 Montreat College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
 Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
